Grosskarlbach, Germany

Peter Noertersheuser

USPTO Granted Patents = 1 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Noertersheuser

Introduction

Peter Noertersheuser is a notable inventor based in Grosskarlbach, Germany. He has made significant contributions to the field of medical treatments, particularly in the area of psoriasis. His innovative approach has led to the development of methods that utilize antibodies to target specific subunits of interleukins.

Latest Patents

Peter Noertersheuser holds 1 patent for his invention titled "Methods for treating psoriasis using antibodies that bind to the P40 subunit of IL-12 and/or IL-23." This patent outlines methods for treating psoriasis by administering an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23. This groundbreaking work has the potential to improve the quality of life for many individuals suffering from this condition.

Career Highlights

Throughout his career, Peter has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with AbbVie Inc. and Abb Vie Deutschland GmbH & Co. KG. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in medical treatments.

Collaborations

Peter Noertersheuser has collaborated with esteemed colleagues in his field, including Joaquin Mario Valdes and Elliot Keith Chartash. These partnerships have fostered an environment of innovation and have led to the development of effective treatment methods.

Conclusion

Peter Noertersheuser's contributions to the field of psoriasis treatment through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in the treatment of this challenging condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…